Sanyou Bio congratulates Dragon Boat Pharmaceutical on the approval of clinical trials of anti-CLDN18.2 antibody drug BC008

/PRNewswire/ -- On April 1, Dragon Boat Pharmaceutical announced that its self-developed anti-CLDN18.2 antibody injection (BC008) had obtained the implied...

Related Keywords

China ,Shanghai ,Caohejing ,Zhangjiang ,Zhejiang ,Guilin Sanjin ,Lang Guojun ,Huang Yingfeng ,Sanyou Bio , ,Boat Pharmaceutical ,Dragon Boat Pharmaceutical ,General Manager ,Zhangjiang High Tech Park ,Caohejing Hi Tech Park ,Sanyou Biopharmaceuticals ,